| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2010PNAS..107.3770S |
| P356 | DOI | 10.1073/PNAS.0915162107 |
| P932 | PMC publication ID | 2840514 |
| P698 | PubMed publication ID | 20133713 |
| P5875 | ResearchGate publication ID | 41408565 |
| P50 | author | Rino Rappuoli | Q2154243 |
| Mariagrazia Pizza | Q100420770 | ||
| Alessia Biolchi | Q101409696 | ||
| Marzia Monica Giuliani | Q104482851 | ||
| Laura Santini | Q104482853 | ||
| Maria Scarselli | Q114320978 | ||
| Silvana Savino | Q114320980 | ||
| Beatrice Aricò | Q114321062 | ||
| Laura Ciucchi | Q114738870 | ||
| Davide Serruto | Q114738872 | ||
| Tiziana Spadafina | Q114738878 | ||
| Marta Tontini | Q114738879 | ||
| Francesco Berti | Q117835530 | ||
| Kate L Seib | Q42328606 | ||
| Paolo Costantino | Q44846314 | ||
| P2093 | author name string | Andrew G Plaut | |
| J Simon Kroll | |||
| Jiazhou Qiu | |||
| Richard Moxon | |||
| Sanjay Ram | |||
| Lisa A Lewis | |||
| John J Donnelly | |||
| Clíona O'Dwyer | |||
| P2860 | cites work | Human milk lactoferrin inactivates two putative colonization factors expressed by Haemophilus influenzae | Q22003949 |
| Identification of a heparin-binding hemagglutinin present in mycobacteria | Q28486374 | ||
| Heparin and heparan sulfate: structure and function | Q31097715 | ||
| Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing. | Q33892877 | ||
| Localization of the heparin-binding site on complement factor H | Q67902469 | ||
| Identification of multiple sites of interaction between heparin and the complement system | Q70699961 | ||
| Capsule phase variation in Neisseria meningitidis serogroup B by slipped-strand mispairing in the polysialyltransferase gene (siaD): correlation with bacterial invasion and the outbreak of meningococcal disease | Q71538870 | ||
| Sequence constancies and variations in genes encoding three new meningococcal vaccine candidate antigens | Q81560667 | ||
| Prevalence and sequence variations of the genes encoding the five antigens included in the novel 5CVMB vaccine covering group B meningococcal disease | Q83222896 | ||
| Functional significance of factor H binding to Neisseria meningitidis | Q83918204 | ||
| Interlaboratory standardization of the measurement of serum bactericidal activity by using human complement against meningococcal serogroup b, strain 44/76-SL, before and after vaccination with the Norwegian MenBvac outer membrane vesicle vaccine | Q33910760 | ||
| Sulfated polysaccharide-directed recruitment of mammalian host proteins: a novel strategy in microbial pathogenesis | Q34001696 | ||
| Kinetic studies on the interactions of heparin and complement proteins using surface plasmon resonance | Q34068498 | ||
| Autotransported serine protease A of Neisseria meningitidis: an immunogenic, surface-exposed outer membrane, and secreted protein. | Q34127907 | ||
| Enhanced bacterial virulence through exploitation of host glycosaminoglycans | Q34611457 | ||
| Epidemic meningitis, meningococcaemia, and Neisseria meningitidis | Q34644525 | ||
| Human milk lactoferrin is a serine protease that cleaves Haemophilus surface proteins at arginine-rich sites | Q34648253 | ||
| Heparin protects Opa+ Neisseria gonorrhoeae from the bactericidal action of normal human serum | Q35409397 | ||
| Microbial adherence to and invasion through proteoglycans | Q35533138 | ||
| Progress towards the development of new vaccines against whooping cough | Q35624976 | ||
| A universal vaccine for serogroup B meningococcus | Q36101910 | ||
| The meningococcal vaccine candidate GNA1870 binds the complement regulatory protein factor H and enhances serum resistance | Q36470692 | ||
| Vaccine-induced opsonophagocytic immunity to Neisseria meningitidis group B. | Q36672529 | ||
| Conquering the meningococcus | Q36711456 | ||
| Mechanisms of avoidance of host immunity by Neisseria meningitidis and its effect on vaccine development | Q37531325 | ||
| Glycosaminoglycans: molecular properties, protein interactions, and role in physiological processes | Q37671601 | ||
| Sulfated glycoconjugate receptors for the Bordetella pertussis adhesin filamentous hemagglutinin (FHA) and mapping of the heparin-binding domain on FHA. | Q38302979 | ||
| Distribution and genetic variability of three vaccine components in a panel of strains representative of the diversity of serogroup B meningococcus | Q39981028 | ||
| Intimate adhesion of Neisseria meningitidis to human epithelial cells is under the control of the crgA gene, a novel LysR-type transcriptional regulator | Q40387262 | ||
| Neisseria meningitidis producing the Opc adhesin binds epithelial cell proteoglycan receptors | Q41046627 | ||
| Characterization of fHbp, nhba (gna2132), nadA, porA, sequence type (ST), and genomic presence of IS1301 in group B meningococcal ST269 clonal complex isolates from England and Wales | Q41845489 | ||
| Ex vivo model of meningococcal bacteremia using human blood for measuring vaccine-induced serum passive protective activity | Q42173007 | ||
| Many carried meningococci lack the genes required for capsule synthesis and transport | Q43450474 | ||
| Analysis of transcriptional control mechanisms of capsule expression in Neisseria meningitidis | Q43811753 | ||
| A Neisserial autotransporter NalP modulating the processing of other autotransporters | Q44655589 | ||
| Antibody to genome-derived neisserial antigen 2132, a Neisseria meningitidis candidate vaccine, confers protection against bacteremia in the absence of complement-mediated bactericidal activity | Q46121635 | ||
| Neisseria meningitidis group B correlates of protection and assay standardization--international meeting report Emory University, Atlanta, Georgia, United States, 16-17 March 2005. | Q53252856 | ||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Neisseria meningitidis | Q154625 |
| P304 | page(s) | 3770-3775 | |
| P577 | publication date | 2010-02-03 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | Neisseria meningitidis GNA2132, a heparin-binding protein that induces protective immunity in humans | |
| P478 | volume | 107 |
| Q33820835 | 1H, 13C and 15N assignment of the C-terminal domain of GNA2132 from Neisseria meningitidis |
| Q37878478 | A combination recombinant protein and outer membrane vesicle vaccine against serogroup B meningococcal disease. |
| Q46272338 | A deeper mining on the protein composition of VA-MENGOC-BC®: An OMV-based vaccine against N. meningitidis serogroup B and C. |
| Q64106983 | A homopolymeric adenosine tract in the promoter region of nspA influences factor H-mediated serum resistance in Neisseria meningitidis |
| Q57808501 | A meningococcal native outer membrane vesicle vaccine with attenuated endotoxin and overexpressed Factor H binding protein elicits gonococcal bactericidal antibodies |
| Q38132262 | A multicomponent serogroup B meningococcal vaccine is licensed for use in Europe: what do we know, and what are we yet to learn? |
| Q39489794 | A naturally occurring single-residue mutation in the translocator domain of Neisseria meningitidis NhhA affects trimerization, surface localization, and adhesive capabilities |
| Q37980186 | A structural perspective on lactoferrin function |
| Q38200261 | A vaccine against serogroup B Neisseria meningitidis: dealing with uncertainty |
| Q89734659 | Adsorption onto aluminum hydroxide adjuvant protects antigens from degradation |
| Q38040527 | Advances with vaccination against Neisseria meningitidis |
| Q84490646 | An alternative renewable source of squalene for use in emulsion adjuvants |
| Q34746633 | An analysis of the sequence variability of meningococcal fHbp, NadA and NHBA over a 50-year period in the Netherlands |
| Q55608033 | Anticoagulants impact on innate immune responses and bacterial survival in whole blood models of Neisseria meningitidis infection. |
| Q43603825 | Bactericidal antibody against a representative epidemiological meningococcal serogroup B panel confirms that MATS underestimates 4CMenB vaccine strain coverage |
| Q37994540 | Bexsero: a multicomponent vaccine for prevention of meningococcal disease. |
| Q36708030 | Biochemistry and pathophysiology of intravascular and intracellular lipolysis |
| Q39410503 | Biological Functions of the Secretome of Neisseria meningitidis |
| Q59244167 | Capsule null locus meningococci: Typing of antigens used in an investigational multicomponent meningococcus serogroup B vaccine |
| Q43973252 | Characterization and Distribution of the autB Gene in Neisseria meningitidis |
| Q35359280 | Characterization of vaccine antigens of meningococcal serogroup W isolates from Ghana and Burkina Faso from 2003 to 2009. |
| Q39667409 | Comparative genome biology of a serogroup B carriage and disease strain supports a polygenic nature of meningococcal virulence |
| Q42935645 | Comparative proteome analysis of spontaneous outer membrane vesicles and purified outer membranes of Neisseria meningitidis |
| Q58697374 | Competence-induced protein Ccs4 facilitates pneumococcal invasion into brain tissue and virulence in meningitis |
| Q36936278 | Conservation of meningococcal antigens in the genus Neisseria |
| Q38011317 | Considerations for controlling invasive meningococcal disease in high income countries |
| Q34594327 | Cooperative serum bactericidal activity between human antibodies to meningococcal factor H binding protein and neisserial heparin binding antigen. |
| Q41912569 | Crystal structures of human Fabs targeting the Bexsero meningococcal vaccine antigen NHBA |
| Q57606160 | Disordered epitopes as peptide vaccines |
| Q33600936 | Diversity of Greek meningococcal serogroup B isolates and estimated coverage of the 4CMenB meningococcal vaccine |
| Q37124721 | Does binding of complement factor H to the meningococcal vaccine antigen, factor H binding protein, decrease protective serum antibody responses? |
| Q30234958 | Emerging experience with meningococcal serogroup B protein vaccines |
| Q36100035 | Epitope Mapping of a Monoclonal Antibody Directed against Neisserial Heparin Binding Antigen Using Next Generation Sequencing of Antigen-Specific Libraries |
| Q33743433 | Evaluation of anticoagulants for serologic assays of cholera vaccination |
| Q38727487 | Expression of the Gene for Autotransporter AutB of Neisseria meningitidis Affects Biofilm Formation and Epithelial Transmigration. |
| Q38829564 | Fighting Neisseria meningitidis: past and current vaccination strategies |
| Q37798011 | Genetic shifts ofNeisseria meningitidisserogroup B antigens and the quest for a broadly cross-protective vaccine |
| Q38099207 | Genome-based bacterial vaccines: current state and future outlook. |
| Q36253028 | Genomic Epidemiology of Hypervirulent Serogroup W, ST-11 Neisseria meningitidis |
| Q38273272 | Genomic and global approaches to unravelling how hypermutable sequences influence bacterial pathogenesis. |
| Q91796776 | Genomic surveillance of invasive meningococcal disease in the Czech Republic, 2015-2017 |
| Q52576392 | Glycointeractions in bacterial pathogenesis. |
| Q38665863 | Heparin Mimics Extracellular DNA in Binding to Cell Surface-Localized Proteins and Promoting Staphylococcus aureus Biofilm Formation |
| Q26782340 | How the Knowledge of Interactions between Meningococcus and the Human Immune System Has Been Used to Prepare Effective Neisseria meningitidis Vaccines |
| Q34237895 | Human factor H (FH) impairs protective meningococcal anti-FHbp antibody responses and the antibodies enhance FH binding |
| Q52682421 | Human protective response induced by meningococcus B vaccine is mediated by the synergy of multiple bactericidal epitopes. |
| Q36156159 | Identification of Ata, a multifunctional trimeric autotransporter of Acinetobacter baumannii. |
| Q38670395 | Identification of a Large Family of Slam-Dependent Surface Lipoproteins in Gram-Negative Bacteria |
| Q40260742 | Immunogenicity and safety of an investigational multicomponent, recombinant, meningococcal serogroup B vaccine (4CMenB) administered concomitantly with routine infant and child vaccinations: results of two randomised trials |
| Q56706209 | Immunogenicity and tolerability of a multicomponent meningococcal serogroup B (4CMenB) vaccine in healthy adolescents in Chile: a phase 2b/3 randomised, observer-blind, placebo-controlled study |
| Q42365570 | Impact of Moderate Temperature Changes on Neisseria meningitidis Adhesion Phenotypes and Proteome. |
| Q37037083 | Importance of inhibition of binding of complement factor H for serum bactericidal antibody responses to meningococcal factor H-binding protein vaccines |
| Q84253443 | Improved OMV vaccine against Neisseria meningitidis using genetically engineered strains and a detergent-free purification process |
| Q36177419 | In-silico prediction and deep-DNA sequencing validation indicate phase variation in 115 Neisseria meningitidis genes. |
| Q21131308 | Inferring reasons for the failure of Staphylococcus aureus vaccines in clinical trials |
| Q40316054 | Influence of medium components on the expression of recombinant lipoproteins in Escherichia coli |
| Q82734196 | Influence of sequence variability on bactericidal activity sera induced by Factor H binding protein variant 1.1. |
| Q30842560 | Interstrain Cooperation in Meningococcal Biofilms: Role of Autotransporters NalP and AutA |
| Q44642888 | Involvement of three meningococcal surface-exposed proteins, the heparin-binding protein NhbA, the α-peptide of IgA protease and the autotransporter protease NalP, in initiation of biofilm formation |
| Q36022991 | Ion torrent personal genome machine sequencing for genomic typing of Neisseria meningitidis for rapid determination of multiple layers of typing information |
| Q34145626 | Lipoproteins of Bacterial Pathogens |
| Q54329423 | Measuring antigen-specific bactericidal responses to a multicomponent vaccine against serogroup B meningococcus. |
| Q26782285 | Meningococcal B Vaccination (4CMenB) in Infants and Toddlers |
| Q34376170 | Meningococcal disease and the complement system |
| Q35682318 | Meningococcal serogroup B vaccine (4CMenB): Booster dose in previously vaccinated infants and primary vaccination in toddlers and two-year-old children |
| Q33703560 | Molecular and serological diversity of Neisseria meningitidis carrier strains isolated from Italian students aged 14 to 22 years. |
| Q36286634 | Molecular characterization of invasive capsule null Neisseria meningitidis in South Africa |
| Q93192113 | Monocyte-activation test to reliably measure the pyrogenic content of a vaccine: An in vitro pyrogen test to overcome in vivo limitations |
| Q30235072 | Multicomponent meningococcal B vaccination (4CMenB) of adolescents and college students in the United States |
| Q92339971 | NHBA is processed by kallikrein from human saliva |
| Q52631109 | Neisseria Heparin Binding Antigen is targeted by the human alternative pathway C3-convertase. |
| Q37932528 | Neisseria meningitidis B vaccines. |
| Q38183156 | Neisseria meningitidis B vaccines: recent advances and possible immunization policies. |
| Q37474854 | Neisseria meningitidis NalP cleaves human complement C3, facilitating degradation of C3b and survival in human serum |
| Q38363907 | Neisseria meningitidis factor H-binding protein fHbp: a key virulence factor and vaccine antigen. |
| Q36173992 | Neisserial Heparin Binding Antigen (NHBA) Contributes to the Adhesion of Neisseria meningitidis to Human Epithelial Cells |
| Q39118087 | Neisserial surface lipoproteins: structure, function and biogenesis |
| Q37690815 | New versus old meningococcal group B vaccines: how the new ones may benefit infants & toddlers |
| Q39215403 | Novel approaches to Neisseria meningitidis vaccine design. |
| Q34428168 | Opc expression, LPS immunotype switch and pilin conversion contribute to serum resistance of unencapsulated meningococci |
| Q93073290 | Persistence of the immune response after 4CMenB vaccination, and the response to an additional booster dose in infants, children, adolescents, and young adults |
| Q33603065 | Phase variation mediates reductions in expression of surface proteins during persistent meningococcal carriage |
| Q52361221 | Prevalence and genetic characteristics of 4CMenB and rLP2086 vaccine candidates among Neisseria meningitidis serogroup B strains, China. |
| Q64128195 | Prevalence and genetic diversity of candidate vaccine antigens among invasive Neisseria meningitidis isolates in the United States |
| Q34921091 | Prevalence and phase variable expression status of two autotransporters, NalP and MspA, in carriage and disease isolates of Neisseria meningitidis. |
| Q28080522 | Prevention of rare diseases: how revolutionary techniques can help vulnerable individuals-the example of serogroup B meningococcal infection |
| Q30354618 | Proteinaceous determinants of surface colonization in bacteria: bacterial adhesion and biofilm formation from a protein secretion perspective. |
| Q34320259 | Qualitative and quantitative assessment of meningococcal antigens to evaluate the potential strain coverage of protein-based vaccines |
| Q35191828 | Recognition of Neisseria meningitidis by the long pentraxin PTX3 and its role as an endogenous adjuvant |
| Q37880078 | Recombinant protein meningococcal serogroup B vaccine combined with outer membrane vesicles |
| Q37563627 | Serum Bactericidal Antibody Responses of Adults Immunized with the MenB-4C Vaccine against Genetically Diverse Serogroup B Meningococci. |
| Q48090618 | Slam is an outer membrane protein that is required for the surface display of lipidated virulence factors in Neisseria |
| Q83159326 | Structural characterisation, stability and antibody recognition of chimeric NHBA-GNA1030: an investigational vaccine component against Neisseria meningitidis |
| Q27674699 | Structure of the C-terminal Domain of Neisseria Heparin Binding Antigen (NHBA), One of the Main Antigens of a Novel Vaccine against Neisseria meningitidis |
| Q57168106 | Structures of NHBA elucidate a broadly conserved epitope identified by a vaccine induced antibody |
| Q91918184 | Subversion of host immune responses by otopathogens during otitis media |
| Q36316767 | Susceptibility of Meningococcal Strains Responsible for Two Serogroup B Outbreaks on U.S. University Campuses to Serum Bactericidal Activity Elicited by the MenB-4C Vaccine |
| Q52562794 | The Bexsero Neisseria meningitidis serogroup B vaccine antigen NHBA is a high-affinity chondroitin sulfate binding protein. |
| Q39036846 | The C2 fragment from Neisseria meningitidis antigen NHBA increases endothelial permeability by destabilizing adherens junctions |
| Q64108196 | The Development of a Vaccine Against Meningococcus B Using Reverse Vaccinology |
| Q38335257 | The Long Road to an Effective Vaccine for Meningococcus Group B (MenB). |
| Q36139946 | The Phosphocarrier Protein HPr Contributes to Meningococcal Survival during Infection |
| Q33915909 | The glycointeractome of serogroup B Neisseria meningitidis strain MC58. |
| Q43447007 | The meningococcal autotransporter AutA is implicated in autoaggregation and biofilm formation. |
| Q35989852 | The new multicomponent vaccine against meningococcal serogroup B, 4CMenB: immunological, functional and structural characterization of the antigens |
| Q38677309 | The next chapter for group B meningococcal vaccines |
| Q50922458 | The role of anti-NHba antibody in bactericidal activity elicited by the meningococcal serogroup B vaccine, MenB-4C. |
| Q40165094 | The sweet side of the pathogenic Neisseria: the role of glycan interactions in colonisation and disease |
| Q36558734 | Transcriptional regulation of the nadA gene in Neisseria meningitidis impacts the prediction of coverage of a multicomponent meningococcal serogroup B vaccine |
| Q39426398 | Vaccines, reverse vaccinology, and bacterial pathogenesis |
| Q42223921 | Variability of genes encoding surface proteins used as vaccine antigens in meningococcal endemic and epidemic strain panels from Norway |
| Q58744473 | Whole genome sequencing of Neisseria meningitidis W isolates from the Czech Republic recovered in 1984-2017 |
Search more.